SCM
MLNT

Stonepine Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Stonepine Capital Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-391,719
Closed -$7.74M – 32
2018
Q3 		$7.74M Buy
391,719
+381,279
+3,652% +$7.53M 4.52% 7
2018
Q2 		$331K Buy
+10,440
New +$331K 0.2% 24